Lipid metabolism regulation pathways (None)

Lipid metabolism regulation pathways represent the integrated network of biochemical reactions and transport mechanisms that maintain the homeostasis of fats, including cholesterol, triglycerides, and phospholipids, within the human body (StatPearls, 2023). These pathways are essential for energy production via fatty acid oxidation, the structural integrity of cellular membranes, and the synthesis of vital signaling molecules such as steroid hormones and bile acids (NCBI, 2022). Key regulatory components within these pathways include enzymes like HMG-CoA reductase, transport proteins such as the LDL receptor, and nuclear receptors like PPARs and SREBPs that coordinate gene expression (PubMed, 2021). Dysregulation of these pathways is a central driver of metabolic diseases, most notably atherosclerosis, dyslipidemia, and non-alcoholic fatty liver disease (NAFLD), which significantly increase cardiovascular risk (AHA, 2023). Pharmacological interventions target specific nodes within these pathways, such as statins for cholesterol synthesis inhibition or fibrates for enhancing fatty acid clearance (PubChem, 2024). Because this term encompasses a broad set of biological processes rather than a single molecular entity, it serves as a functional category for various therapeutic targets in metabolic medicine (Wikipedia, 2024).

Other names

Lipid metabolismLipid homeostasisFatty acid and cholesterol metabolismLipid metabolic process

Inhibition of HMG-CoA reductase, activation of PPAR-alpha, inhibition of NPC1L1, inhibition of PCSK9, and inhibition of ATP citrate lyase (StatPearls, 2023; PubChem, 2024).